FGFR3 and renal cell adenocarcinoma: Two patients (9%) harboured a mutation of the FGFR3 gene (F386L); in both cases it was associated with a VHL1 mutation (1 cases also with a PTEN mutation) and each patient presented respectively the mutation both in the primary RCC and the corresponding metastasis and the clear cell and in the rhabdoid component.